Is Inhibrx Biosciences Inc. (INBX) a Buy, Sell, or Hold?
NASDAQ : INBX
Inhibrx Biosciences Inc. — Competitors
$79.68 USD
-$2.77 (-3.36%)
- Volume
- 185.77K
- Average Volume
- 401.63K
- Market Capitalization
- $1.17B
- P/E Ratio
- -9.50
- Dividend Yield
- 0.00%
- Price Target
- $325.00
- Year High
- $155.29
- Year Low
- $20.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.46
INBX vs. The Competition
| Properties | INBX | AMLX | ATAI | CVAC |
|---|---|---|---|---|
| Market Cap | $1.17B | $2.17B | $2.66B | $1.05B |
| Shares Outstanding | $14.67M | $111.19M | $369.95M | $225.17M |
| P/E Ratio | -9.5 | -13.21 | -2.39 | 5.68 |
| EPS | -8.35 | -1.36 | -2.93 | 0.72 |
| Day Low | 78.065 | 18.905 | 7.15 | 4.57 |
| Day High | 84.1 | 19.99 | 7.1966 | 4.66 |
| Year Low | 20.55 | 7.48 | 3.265 | 2.475 |
| Year High | 155.29 | 19.99 | 7.22 | 5.72 |
| Average Price 50 | 94.8569 | 15.9795 | 4.9924 | 4.9678 |
| Average Price 200 | 83.0719 | 14.74515 | 4.38473 | 4.84573 |
| Volume | 185.77K | 2.87M | 17.21M | 728.78K |
| Average Volume | - | - | - | - |